{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:40:57Z","timestamp":1790718057977,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["PPRND-150732163"],"award-info":[{"award-number":["PPRND-150732163"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","award":["K23AR068449"],"award-info":[{"award-number":["K23AR068449"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30AR072583"],"award-info":[{"award-number":["P30AR072583"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.semarthrit.2022.152083","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T14:44:20Z","timestamp":1660747460000},"page":"152083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs \u2013 Analysis of a national claims database"],"prefix":"10.1016","volume":"57","author":[{"given":"Sebastian E.","family":"Sattui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Navarro-Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangala","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semarthrit.2022.152083_bib0001","first-page":"3","article-title":"CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors\u2013United States, 2005-2013","volume":"63","author":"Johnson","year":"2014","journal-title":"MMWR Suppl"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152083_bib0002","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/jnnp.2005.072983","article-title":"Quality of life in dementia: more than just cognition. An analysis of associations with quality of life in dementia","volume":"77","author":"Banerjee","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.semarthrit.2022.152083_bib0003","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-014-0192-4","article-title":"Comorbidity and dementia: a scoping review of the literature","volume":"12","author":"Bunn","year":"2014","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152083_bib0004","doi-asserted-by":"crossref","first-page":"e12050","DOI":"10.1002\/trc2.12050","article-title":"Alzheimer's disease drug development pipeline: 2020","volume":"6","author":"Cummings","year":"2020","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.semarthrit.2022.152083_bib0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer's disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimer's Dement"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152083_bib0006","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/cts.12491","article-title":"Lessons learned from Alzheimer disease: clinical trials with negative outcomes","volume":"11","author":"Cummings","year":"2018","journal-title":"Clin Transl Sci."},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152083_bib0007","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12974-018-1313-3","article-title":"Inflammation: the link between comorbidities, genetics, and Alzheimer's disease","volume":"15","author":"Newcombe","year":"2018","journal-title":"J Neuroinflamm"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152083_bib0008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11910-015-0531-7","article-title":"The role of neuroinflammation in dementias","volume":"15","author":"Pasqualetti","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152083_bib0009","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3233\/JAD-200711","article-title":"Therapeutic potential of TNF-alpha inhibition for Alzheimer's disease prevention","volume":"78","author":"Torres-Acosta","year":"2020","journal-title":"J Alzheimer's Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152083_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: Extra-articular manifestations and comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2022.152083_bib0011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41927-018-0014-y","article-title":"Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment","volume":"2","author":"Jagpal","year":"2018","journal-title":"BMC Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152083_bib0012","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152083_bib0013","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12974-021-02086-2","article-title":"Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis","volume":"18","author":"Lai","year":"2021","journal-title":"J Neuroinflamm"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152083_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031185","article-title":"Cognitive decline in rheumatoid arthritis: insight into the molecular pathogenetic mechanisms","volume":"22","author":"Basile","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152083_bib0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.semarthrit.2020.09.022","article-title":"Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis","volume":"51","author":"Sattui","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152083_bib0016","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13195-020-00606-5","article-title":"Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis: a multi-national multi-database case-control study","volume":"12","author":"Newby","year":"2020","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.semarthrit.2022.152083_bib0017","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00715-6","article-title":"Can disease-modifying anti-rheumatic drugs reduce the risk of developing dementia in patients with rheumatoid arthritis?","author":"Huang","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152083_bib0018","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/gps.4793","article-title":"The influence of TNF inhibitors on dementia incidence in patients with rheumatoid arthritis; an analysis from the BSRBR-RA","volume":"33","author":"McGuinness","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152083_bib0019","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.trci.2017.10.002","article-title":"Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients","volume":"3","author":"Judge","year":"2017","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.semarthrit.2022.152083_bib0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.taap.2017.09.014","article-title":"DMARD use is associated with a higher risk of dementia in patients with rheumatoid arthritis: a propensity score-matched case-control study","volume":"334","author":"Chou","year":"2017","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152083_bib0021","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s40263-016-0374-z","article-title":"Treatment for rheumatoid arthritis and risk of Alzheimer's disease: a nested case-control analysis","volume":"30","author":"Chou","year":"2016","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152083_bib0022","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/ar3260","article-title":"Validation of rheumatoid arthritis diagnoses in health care utilization data","volume":"13","author":"Kim","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152083_bib0023","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/acr.20629","article-title":"Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice","volume":"63","author":"Cannon","year":"2011","journal-title":"Arthrit Care Res"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152083_bib0024","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","article-title":"Active-comparator design and new-user design in observational studies","volume":"11","author":"Yoshida","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152083_bib0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/pds.3449","article-title":"Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors","volume":"22","author":"Hebert","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152083_bib0026","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3233\/JAD-2009-1099","article-title":"The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited","volume":"17","author":"Taylor","year":"2009","journal-title":"J Alzheimer's Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152083_bib0027","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jalz.2009.09.001","article-title":"An examination of Alzheimer's disease case definitions using Medicare claims and survey data","volume":"6","author":"Lin","year":"2010","journal-title":"Alzheimer's Dement"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152083_bib0028","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00005650-200208000-00007","article-title":"Validity of information on comorbidity derived ROM ICD-9-CCM administrative data","volume":"40","author":"Quan","year":"2002","journal-title":"Med Care"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152083_bib0029","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.semarthrit.2022.152083_bib0030","unstructured":"(CMS) CfMMS. Chronic Conditions Data Warehouse. https:\/\/www.ccwdata.org\/web\/guest\/condition-categories. Accessed 5\/2, 2019."},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152083_bib0031","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"446","key":"10.1016\/j.semarthrit.2022.152083_bib0032","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Statist Assoc"},{"issue":"9596","key":"10.1016\/j.semarthrit.2022.152083_bib0033","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2022.152083_bib0034","article-title":"Rheumatoid arthritis and neurodegenerative dementia: a nested case-control study and a follow-up study using a national sample cohort","author":"Min","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152083_bib0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.autrev.2018.04.001","article-title":"Inflammation and dementia: Using rheumatoid arthritis as a model to develop treatments?","volume":"17","author":"Mason","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2022.152083_bib0036","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fnins.2018.00627","article-title":"Alzheimer's disease and rheumatoid arthritis: a mendelian randomization study","volume":"12","author":"Cai","year":"2018","journal-title":"Front Neurosci"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152083_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168106","article-title":"Rheumatoid arthritis was negatively associated with Alzheimer's disease: a population-based case-control study","volume":"11","author":"Kao","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152083_bib0038","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/IJPSYM.IJPSYM_45_20","article-title":"Reverse causation, physical inactivity, and dementia","volume":"42","author":"Andrade","year":"2020","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.semarthrit.2022.152083_bib0039","doi-asserted-by":"crossref","first-page":"l1495","DOI":"10.1136\/bmj.l1495","article-title":"Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis","volume":"365","author":"Kivim\u00e4ki","year":"2019","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152083_bib0040","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2018.11499","article-title":"Association of cardiovascular health level in older age with cognitive decline and incident dementia","volume":"320","author":"Samieri","year":"2018","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152083_bib0041","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s11606-020-05895-y","article-title":"Age and incidence of dementia diagnosis","volume":"36","author":"Olfson","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152083_bib0042","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","article-title":"Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies","volume":"88","author":"Lai","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152083_bib0043","article-title":"Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease","author":"Jaturapatporn","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152083_bib0044","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/WNL.55.7.1067","article-title":"A randomized controlled trial of prednisone in Alzheimer's disease","volume":"55","author":"Koch","year":"2000","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.semarthrit.2022.152083_bib0045","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1212\/WNL.0000000000001617","article-title":"Etanercept in Alzheimer disease: a randomized, placebo-controlled, double-blind, phase 2 trial","volume":"84","author":"Butchart","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152083_bib0046","first-page":"25","article-title":"TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study","volume":"8","author":"Tobinick","year":"2006","journal-title":"MedGenMed"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152083_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229819","article-title":"Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis","volume":"15","author":"Zhou","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152083_bib0048","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.6567","article-title":"Comparative risk of alzheimer disease and related dementia among medicare beneficiaries with rheumatoid arthritis treated with targeted disease-modifying antirheumatic agents","volume":"5","author":"Desai","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152083_bib0049","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/acr.23875","article-title":"Comparative risk of cardiovascular events with biologic and synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"72","author":"Singh","year":"2020","journal-title":"Arthrit Care Res"},{"key":"10.1016\/j.semarthrit.2022.152083_bib0050","article-title":"The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis","author":"Ozen","year":"2020","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152083_bib0051","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/annrheumdis-2018-214075","article-title":"Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial","volume":"78","author":"Burggraaf","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152083_bib0052","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002093-200210000-00001","article-title":"Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank","volume":"16","author":"Barker","year":"2002","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"24","key":"10.1016\/j.semarthrit.2022.152083_bib0053","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:08:56Z","timestamp":1758733736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222001342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":53,"alternative-id":["S0049017222001342"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152083","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs \u2013 Analysis of a national claims database","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152083"}}